Galderma to Acquire ZO Skin Health for $1.5 Billion
Galderma, maker of Cetaphil, will acquire physician-dispensed skincare brand ZO Skin Health for $1.5 billion, deepening its push into medical-grade skincare.
Topic
Mergers And Acquisitions
Topic
Mergers And Acquisitions
Galderma to pay $1.5B for Zo Skin Health, expanding dermatology footprint
Galderma's $1.5 billion bid for Zo Skin Health, first reported by Fierce Pharma, ranks among the year's largest bets on physician…
Galderma Agrees to Buy ZO Skin Health for About $1.5 Billion
Galderma has agreed to acquire physician-founded ZO Skin Health for about $1.5 billion, sources say, uniting a dermatology drug a…
DermCare Management and U.S. Dermatology Partners Complete Merger
DermCare Management and U.S. Dermatology Partners have completed a strategic combination, creating one of the largest dermatology…